Showing results (1-10 of 219) with videos related to
Sort By:
Pageof 22
Journal of Cell Science|February 21, 2014
Small regulators, major consequences - Ca²⁺ and cholesterol at the endosome-ER interfaceRik van der Kant, Jacques NeefjesTrends in Neurosciences|January 14, 2014
Stuck in traffic: an emerging theme in diseases of the nervous systemJacques Neefjes, Rik van der KantJournal of Lipid Research|May 28, 2013
Cholesterol-binding molecules MLN64 and ORP1L mark distinct late endosomes with transporters ABCA3 and NPC1Rik van der Kant, Ilse Zondervan, Lennert Janssen, et al.The Journal of Cell Biology|July 1, 2009
Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endosome positioningNuno Rocha, Coenraad Kuijl, Rik van der Kant, et al.The Journal of Biological Chemistry|October 15, 2015
Characterization of the Mammalian CORVET and HOPS Complexes and Their Modular Restructuring for Endosome SpecificityRik van der Kant, Caspar T H Jonker, Ruud H Wijdeven, et al.Cellular and Molecular Life Sciences : CMLS|January 21, 2012
Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartmentsKristiina Uusi-Rauva, Aija Kyttälä, Rik van der Kant, et al.Journal of Cell Science|June 5, 2013
Late endosomal transport and tethering are coupled processes controlled by RILP and the cholesterol sensor ORP1LRik van der Kant, Alexander Fish, Lennert Janssen, et al.Frontiers in Aging Neuroscience|July 12, 2021
Cholesterol and Alzheimer's Disease; From Risk Genes to Pathological EffectsFemke M Feringa, Rik van der KantThe Journal of Cell Biology|March 11, 2024
An inside job: New roles for ApoE at the lipid dropletFemke M Feringa, Rik van der KantThe Lancet. Neurology|June 1, 2022
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trialsRik Ossenkoppele, Rik van der Kant, Oskar HanssonPageof 22